Simple Business Model:
We Supply the Excipient. You Formulate — Sonanos™.

Our envisioned business model is very simple. We aim to manufacture and sell Sonanos™ as a pharmaceutical excipient, primarily supplying pharmaceutical companies and receiving payment for the excipient.

We intend to allow cusomers to acquire patents on formulations limited to customer’s proprietary APIs, except for a certain application (cancer vaccines).

We are open to adjusting the collaboration style to suit your needs within the scope of our business model. Please contact us for details.

We intend to:

  • Allow customers to conduct formulation research for pharmaceuticals utilizing Sonanos™.
  • Allow customers to acquire patents on formulations limited to customer’s proprietary APIs.


Note: If you wish to use Sonanos™ for cancer vaccines, please contact us first.

We Welcome Passionate Collaborators:
Start with Sonanos™ — Paid Samples Available Under MTA.
Contact Us to Begin.

We can offer Sonanos™ paid samples under Materials Transfer Agreement (MTA) for feasibility studies as a first-step. Contact us if you would like to know more about Sonanos™ or request samples.

Sonanos™ Samples Available on Scientist.com (Optional)

Paid samples of Sonanos™ are also available through the Scientist.com platform. This platform enables you to complete all transactions seamlessly, without the need to establish a conventional MTA via email, as the same MTA terms are incorporated into the Statement of Work (SOW). For more details, please refer to the following link:
https://app.scientist.com/domain_switcher?redirect=/providers/asahi-kasei

User Guides for Sonanos™ Available Online

We provide User guides to support your use of Sonanos™, which include general preparation and evaluation protocols. These guides are available for download from our website upon free registration.

TOP